Cargando…
Hereditary renal glycosuria, diabetes and responses to SGLT2 inhibitor
AIMS: To present the clinical features of two rare cases with hereditary renal glycosuria and diabetes, explore their responses to sodium‐glucose cotransporter 2 (SGLT2) inhibitor, and summarize the reported solute carrier family 5 member 2 (SLC5A2) mutations and related phenotypes. METHODS: Two pat...
Autores principales: | Ren, Qian, Gong, Siqian, Han, Xuyao, Ji, Linong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Publishing Asia Pty Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9060016/ https://www.ncbi.nlm.nih.gov/pubmed/35229480 http://dx.doi.org/10.1111/1753-0407.13254 |
Ejemplares similares
-
SGLT2-inhibitors; more than just glycosuria and diuresis
por: Fathi, Amir, et al.
Publicado: (2020) -
Prolonged ketosis and glycosuria secondary to SGLT2 inhibitor therapy
por: Bobrowski, David, et al.
Publicado: (2021) -
Structural repurposing of SGLT2 inhibitor empagliflozin for strengthening anti-heart failure activity with lower glycosuria
por: Xu, Yixiang, et al.
Publicado: (2023) -
SGLT2 inhibitor lowers serum uric acid through alteration of uric acid transport activity in renal tubule by increased glycosuria
por: Chino, Yukihiro, et al.
Publicado: (2014) -
Bittersweet: infective complications of drug-induced glycosuria in patients with diabetes mellitus on SGLT2-inhibitors: two case reports
por: Bartolo, Caroline, et al.
Publicado: (2021)